2-methyl-1,4-benzoquinone has been researched along with 1,4-naphthoquinone in 3 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (33.33) | 18.2507 |
2000's | 1 (33.33) | 29.6817 |
2010's | 1 (33.33) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Boer, M; Driebergen, RJ; Hilbers, HW; Holthuis, JJ; Janssen, LH; Moret, EE; Reinhoudt, DN; Tollenaere, JP; Verboom, W | 1 |
Carroll, PJ; DuHadaway, JB; Jaller, D; Kumar, S; LaLonde, JM; Malachowski, WP; Metz, R; Muller, AJ; Prendergast, GC | 1 |
Bremer, PT; Hixon, MS; Janda, KD | 1 |
3 other study(ies) available for 2-methyl-1,4-benzoquinone and 1,4-naphthoquinone
Article | Year |
---|---|
In vivo activity and hydrophobicity of cytostatic aziridinyl quinones.
Topics: Animals; Antineoplastic Agents; Benzoquinones; Leukemia L1210; Melanoma, Experimental; Mice | 1996 |
Indoleamine 2,3-dioxygenase is the anticancer target for a novel series of potent naphthoquinone-based inhibitors.
Topics: Animals; Antineoplastic Agents; Binding Sites; Cell Proliferation; Cell Survival; Computer Simulation; Crystallography, X-Ray; Disease Models, Animal; Dose-Response Relationship, Drug; Drug Screening Assays, Antitumor; Enzyme Inhibitors; Indoleamine-Pyrrole 2,3,-Dioxygenase; Mice; Mice, Knockout; Mice, Nude; Models, Molecular; Molecular Structure; Naphthoquinones; Pyrones; Stereoisomerism; Structure-Activity Relationship; Vitamin K 3 | 2008 |
Benzoquinones as inhibitors of botulinum neurotoxin serotype A.
Topics: Benzoquinones; Binding Sites; Botulinum Toxins, Type A; Drug Design; Kinetics; Molecular Docking Simulation; Protease Inhibitors; Protein Binding; Protein Structure, Tertiary; Structure-Activity Relationship | 2014 |